As of 2026-04-03, the EV/EBITDA ratio of Galectin Therapeutics Inc (GALT) is -. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GALT's latest enterprise value is 282.88 mil USD. GALT's TTM EBITDA according to its financial statements is - mil USD. Dividing these 2 quantities gives us the above GALT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative Enterprise Value.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |